Corticosteroid treatment in critically ill patients with pandemic influenza A/H1N1 2009 infection: Analytic strategy using propensity scores

American Journal of Respiratory and Critical Care Medicine

Volumn 183, Issue 9, 2011, Pages 1207-1214

  Kim, Sung Han ^a   Hong, Sang Bum ^a   Yun, Sung Choel ^a   Choi, Won Il ^b   Ahn, Jong Joon ^c   Lee, Young Joo ^d   Lee, Heung Bum ^e   Lim, Chae Man ^a   Koh, Younsuck ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Keimyung University School of Medicine   (South Korea)

^c Ulsan University College of Medicine   (South Korea)

^d Ajou University School of Medicine   (South Korea)

^e Chonbuk National University Medical School   (South Korea)

Author keywords

Critically ill patients; Pandemic influenza A H1N1 2009; Steroid

Indexed keywords

AMANTADINE; HYDROCORTISONE; METHYLPREDNISOLONE; OSELTAMIVIR; PREDNISOLONE; RIBAVIRIN;

ADJUVANT THERAPY; ADULT; ARTICLE; BACTERIAL PNEUMONIA; CASE CONTROL STUDY; CLINICAL FEATURE; CORTICOSTEROID THERAPY; CRITICALLY ILL PATIENT; DRUG EFFECT; DRUG MEGADOSE; FEMALE; HOSPITALIZATION; HUMAN; INFLUENZA; INFLUENZA A (H1N1); INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; MYCOSIS; PANDEMIC; PANDEMIC INFLUENZA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK; SCORING SYSTEM; SOUTH KOREA; STRATIFICATION; SUPERINFECTION; SYMPTOM; TREATMENT INDICATION;

ADRENAL CORTEX HORMONES; COHORT STUDIES; CRITICAL ILLNESS; FEMALE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MIDDLE AGED; ODDS RATIO; PANDEMICS; PNEUMONIA, BACTERIAL; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 79955504922     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201101-0110OC     Document Type: Article

References (37)

1. Chan M. World now at the start of 2009 influenza pandemic [Internet]. 2011 [accessedMarch 2011]. Available from: http://www.who.int/mediacentre/news/ statements/2009/h1n1-pandemic-phase6-20090611/en/index.html
2. World Health Organization. Pandemic (H1N1) 2009-update 98 [Internet]. 2011 [accessed March 2011]. Available from: http://www.who.int/csr/don/2010-04- 30a/en/index.html
3. Na S, Kim MN, Kim WY, Kim W, Hong SB, Lim CM, Koh Y, Kwon JW, Hong SJ, Lee SO, et al. Prevalence and clinical features of pneumonia in patients with laboratory-confirmed pandemic influenza A/H1N1 2009 infection in South Korea. Scand J Infect Dis 2011;43:19-26.
4. Kim SH. [Treatment of severe pandemic influenza A/H1N1 infection] [article in Korean]. Infect Chemother 2009;41:265-271.
5. Perez-Padilla R, de la Rosa-Zamboni D, Ponce de Leon S, Hernandez M, Quiñones-Falconi F, Bautista E, Ramirez-Venegas A, Rojas-Serrano J, Ormsby CE, Corrales A, et al.; INER Working Group on Influenza. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med 2009;361:680-689.
6. ANZIC Influenza Investigators. Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N Engl J Med 2009;361:1925-1934.
7. Rello J, Rodriguez A, Ibanez P, Socias L, Cebrian J, Marques A, Guerrero J, Ruiz-Santana S, Marquez E, Del Nogal-Saez F, et al.; H1N1 SEMICYUC Working Group. Intensive care adult patients with severe respiratory failure caused by influenza A (H1N1) in Spain. Crit Care 2009;13:R148.
8. Dominguez-Cherit G, Lapinsky SE, Macias AE, Pinto R, Espinosa-Perez L, de la Torre A, Poblano-Morales M, Baltazar-Torres JA, Bautista E, Martinez A, et al. Critically ill patients with 2009 influenza A (H1N1) in Mexico. JAMA 2009;302:1880-1887.
9. Kumar A, Zarychanski R, Pinto R, Cook DJ, Marshall J, Lacroix J, Stelfox T, Bagshaw S, Choong K, Lamontagne F, et al.; Canadian Critical Care Trials Group H1N1 Collaborative. Critically ill patients with 2009 influenza A (H1N1) infection in Canada. JAMA 2009;302:1872-1879.
10. Farias JA, Fernandez A, Monteverde E, Vidal N, Arias P, Montes MJ, Rodríguez G, Allasia M, Ratto ME, Jaén R, et al. Critically ill infants and children with influenza A (H1N1) in pediatric intensive care units in Argentina. Intensive Care Med 2010;36:1015-1022.
11. Quispe-Laime AM, Bracco JD, Barberio PA, Campagne CG, Rolfo VE, Umberger R, Meduri GU. H1N1 influenza A virus-associated acute lung injury: response to combination oseltamivir and prolonged corticosteroid treatment. Intensive Care Med 2010;36:33-41.
12. de Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJ, Chau TN, Hoang DM, Chau NV, Khanh TH, Dong VC, et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med 2006;12:1203-1207. (Pubitemid 44527358)
13. Bermejo-Martin JF, Ortiz de Lejarazu R, Rello J, Almansa R, Ramírez P, Martin-Loeches I, Varillas D, Gallegos MC, Serón C, Micheloud D, et al. Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza. Crit Care 2009;13:R201.
14. Takano T, Tajiri H, Kashiwagi Y, Kimura S, Kawashima H. Cytokine and chemokine response in children with the 2009 pandemic influenza A (H1N1) virus infection. Eur J Clin Microbiol Infect Dis 2011;30: 117-120.
15. Confalonieri M, D'Agaro P, Campello C. Corticosteroids do not cause harmful increase of viral load in severe H1N1 virus infection. Intensive Care Med 2010;36:1780-1781.
16. Liem NT, Tung CV, Hien ND, Hien TT, Chau NQ, Long HT, Hien NT, Mai le Q, Taylor WR, Wertheim H, et al. Clinical features of human influenza A (H5N1) infection in Vietnam: 2004-2006. Clin Infect Dis 2009;48:1639-1646.
17. Martin-Loeches I, Lisboa T, Rhodes A, Moreno RP, Silva E, Sprung C, Chiche JD, Barahona D, Villabon M, Balasini C, et al.; ESICM H1N1 Registry Contributors. Use of early corticosteroid therapy on ICU admission in patients affected by severe pandemic (H1N1)v influenza A infection. Intensive Care Med 2011;37:272-283.
18. Kim SH, Park WB, Lee CS, Kang CI, Bang JW, Kim HB, Kim NJ, Kim EC, Oh MD, Choe KW. Outcome of inappropriate empirical antibiotic therapy in patients with Staphylococcus aureus bacteraemia: analytic strategy using propensity scores. Clin Microbiol Infect 2006;12:13-21. (Pubitemid 43372234)
19. Kim SH, Song KH, Choi SJ, Kim HB, Kim NJ, Oh MD, Choe KW. Diagnostic usefulness of a T-cell-based assay for extrapulmonary tuberculosis in immunocompromised patients. Am J Med 2009;122:189-195.
20. COIITSS Study Investigators. Corticosteroid Treatment and Intensive Insulin Therapy for Septic Shock in adults. JAMA 2010;303:341-348.
21. Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika 1983;70:41-55.
22. Gum PA, Thamilarasan M, Watanabe J, Blackstone EH, Lauer MS. Aspirin use and all-cause mortality among patients being evaluated for known or suspected coronary artery disease: a propensity analysis. JAMA 2001;286:1187-1194. (Pubitemid 33015547)
23. Seung KB, Park DW, Kim YH, Lee SW, Lee CW, Hong MK, Park SW, Yun SC, Gwon HC, Jeong MH, et al. Stents versus coronary-artery bypass grafting for left main coronary artery disease. N Engl J Med 2008;358:1781-1792.
24. Sligl WI, Milner DA, Sundar S, Mphatswe W, Majumdar SR. Safety and efficacy of corticosteroids for the treatment of septic shock: a systemic review and meta-analysis. Clin Infect Dis 2009;49:93-101.
25. Annane D, Sebille V, Charpentier C, Bollaert PE, Francxois B, Korach JM, Capellier G, Cohen Y, Azoulay E, Troché G, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisones on mortality in patients with septic shock. JAMA 2002;288:862-871.
26. Dellinger RP, Levy MM, Charlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008;34:17-60.
27. Sprung CL, Annane D, Keh D, Moreno R, Singer M, Freivogel K, Weiss YG, Benbenishty J, Kalenka A, Forst H, et al.; CORTICUS Study Group. Hydrocortisone therapy for patients with septic shock. N Engl J Med 2008;358:111-124.
28. Annane D, Bellissant E, Bollaert PE, Briegel J, Confalonieri M, De Gaudio R, Keh D, Kupfer Y, Oppert M, Meduri GU. Corticosteroids in the treatment of severe sepsis and septic shock in adults. JAMA 2009;301:2362-2375.
29. Writing Committee of the Second World Health Organization Consultation on Clinical Aspects of Human Infection with Avian Influenza A (H5N1) Virus; Abdel-Ghafar AN, Chotpitayasunondh T, Gao Z, Hayden FG, Nguyen DH, de Jong MD, Naghdaliyev A, Peiris JS, Shindo N, Soeroso S, et al. Update on avian influenza A (H5N1) virus infection in humans. N Engl J Med 2008;358:261-273.
30. Boudreault AA, Xie H, Leisenring W, Englund J, Corey L, Boeckh M. Impact of corticosteroid treatment and antiviral therapy on clinical outcomes in hematopoietic cell transplant patients infected with influenza virus. Biol Blood Marrow Transplant (In press)
31. Couch RB, Davis BR. Has oseltamivir been shown to be effective for treatment of H5N1 influenza? J Infect Dis 2010;202:1149-1151.
32. Tang BM, Craig JC, Eslick GD, Seppelt I, McLean AS. Use of corticosteroids in acute lung injury and acute respiratory distress syndrome: a systemic review and meta-analysis. Crit Care Med 2009;37:1593-1603.
33. Steinberg KP, Hudson LD, Goodman RB, Hough CL, Lanken PN, Hyzy R, Thompson BT, Ancukiewicz M; National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med 2006;354:1671-1684.
34. Snijders D, Daniels JM, de Graaff CS, van der Werf TS, Boersma WG. Efficacy of corticosteroids in community-acquired pneumonia: a randomized double-blinded clinical trial. Am J Respir Crit Care Med. 2010;181:975-982.
35. Mauad T, Hajjar LA, CAllegari GD, da Silva LF, Schout D, Galas FR, Alves VA, Malheiros DM, Auler JO Jr, Ferreira AF, et al. Lung pathology in fatal novel human influenza A (H1N1) infection. Am J Respir Crit Care Med 2010;181:72-79.
36. Itoh Y, Shinya K, Kiso M, Watanabe T, Sakoda Y, Hatta M, Muramoto Y, Tamura D, Sakai-Tagawa Y, Noda T, et al. In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 2009;460:1021-1025.
37. Korean Society of Critical Care Medicine. KSCCM H1N1 Registry [Internet]. 2010 (accessed October 13]. Available from: http://www.ksccm.org